Cna Financial Corp Legend Biotech Corp Transaction History

Cna Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$38.15 - $57.1 $11,445 - $17,130	300 Added 4.68%	6,715 $274,000
Q2 2022 Aug 09, 2022	SELL	$33.54 - $55.0 $122,085 - $200,200	-3,640 Reduced 36.2%	6,415 $353,000
Q1 2022 May 10, 2022	SELL	$31.02 - $48.18 $8,995 - $13,972	-290 Reduced 2.8%	10,055 $365,000
Q4 2021 Feb 11, 2022	SELL	$41.14 - $56.98 $33,734 - $46,723	-820 Reduced 7.34%	10,345 $482,000
Q3 2021 Nov 12, 2021	BUY	$35.31 - $50.56 $17,655 - $25,280	500 Added 4.69%	11,165 $565,000
Q2 2021 Aug 12, 2021	SELL	$25.8 - $41.09 $48,168 - $76,715	-1,867 Reduced 14.9%	10,665 $438,000
Q1 2021 May 14, 2021	BUY	$23.55 - $32.4 $121,518 - $167,184	5,160 Added 69.99%	12,532 $364,000
Q4 2020 Feb 12, 2021	SELL	$25.8 - $32.39 $15,738 - $19,757	-610 Reduced 7.64%	7,372 $208,000
Q3 2020 Nov 12, 2020	BUY	$27.5 - $39.61 $52,800 - $76,051	1,920 Added 31.67%	7,982 $246,000
Q2 2020 Aug 13, 2020	BUY	$36.1 - $42.56 $218,838 - $257,998	6,062 New	6,062 $258,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.